FRESENIUS MEDICAL CARE-ADR (FMS) Stock News
NYSE:FMS - New York Stock Exchange, Inc. - US3580291066 - ADR
FMS Latest News and Analysis
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization.
Thursday Sector Laggards: Semiconductors, Diagnostics
Nvidia is Down 21%. Here Are 3 Better Stocks to Buy for the Rest of 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are better stocks to buy instead of Nvidia (NASDAQ:NVDA). Although the ch...
Fresenius Medical Care (FMS) Shares Cross Above 200 DMA
Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway
You can't go wrong by following in the Oracle's footsteps and buying these cheap Buffett stocks before the market catches on.
FMS Stock Earnings: Fresenius Medical Care Beats EPS, Beats Revenue for Q1 2024
FMS stock results show that Fresenius Medical Care beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News
Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease.
Stock Market Whiplash
We've also got a look at the international real estate market.
AbbVie, Amgen cited in latest Medicare inflation penalties
The Biden administration identifies 48 Medicare Part B drugs subject to inflation penalties in Q1 2024. Read more here.
Only Have $100? 3 No-Brainer Stocks to Buy Right Now
The stock market is such a well-oiled, wealth-generating machine that investors can start with just $100 to buy these no-brainer stocks.
Fresenius settles litigation over Tricare program (NYSE:FMS)
Fresenius Medical Care (FMS) on Tuesday said it had entered into a final settlement with the U.S. government over the Tricare program.
Fresenius recalls Sanxin hemodialysis syringes over leakage issues (NYSE:FMS)
Fresenius Medical Care (FMS) has recalled its Sanxin single-use syringes, which are used with its 2008T hemodialysis machines, over reported leakage issues. Read more here.
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.
Capital Square Delivers 149.59% Total Return* to Investors in Medical Building DST
/PRNewswire/ -- Capital Square, one of the nation's leading sponsors of tax-advantaged real estate investments and an active developer and manager of...
Stock Market Rallies, Hits Resistance; Novo Nordisk, JPMorgan, Exxon In Focus: Weekly Review
The major indexes stalled at key levels amid weak breadth.
Fresenius sees GLP-1 drugs having neutral impact on its business: report (FMS)
Fresenius Medical Care said it sees GLP-1 drugs as having a neutral impact on its dialysis business, according to a report. Read more here.
Dialysis stocks decline again as Novo Nordisk hits 52-week high (DVA)
Dialysis stocks declined for the second day as Novo Nordisk shares hit a new 52-week high following an update on Novo's study on Ozempic in the treatment of kidney failure.
Why Dialysis Stocks Plunged Today
Novo Nordisk indicated one of its diabetes drugs could also be used to treat kidney disease. Here's what investors need to know.